Novel antibody associations in immune-mediated necrotising myopathy without inflammation

Irish Journal of Medical Science

Volumn 185, Issue 4, 2016, Pages 941-943

  Curtin, D ^a   Costigan, D ^b   McCarthy, C ^b   Jansen, M ^c   Farrell, M ^c   Reid, V ^a   O'Rourke K ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b MATER PRIVATE HOSPITAL   (Ireland)

^c BEAUMONT HOSPITAL   (Ireland)

Author keywords

3 Hydroxy 3 methyl glutaryl CoA reductase inhibitor; Antibody; Immune mediated; Necrotizing myopathy; Signal recognition particle

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYLCOENZYME A REDUCTASE; ANTIBODY; ATORVASTATIN; CALCIFEDIOL; CALCIUM; CREATINE KINASE; CYCLOPHOSPHAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; SIGNAL RECOGNITION PARTICLE; UNCLASSIFIED DRUG; VITAMIN D; ACYL COENZYME A; AUTOANTIBODY; GLUTARYL-COENZYME A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STEROID;

ADULT; AGED; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISABILITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; MUSCLE ACTION POTENTIAL; MUSCLE BIOPSY; MYOPATHY; MYOSITIS; NECROTISING MYOPATHY; NONINVASIVE VENTILATION; POSITRON EMISSION TOMOGRAPHY; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; REVIEW; SHOULDER PAIN; STEROID THERAPY; TREATMENT RESPONSE; AUTOIMMUNE DISEASE; BLOOD; IMMUNOLOGY; MUSCULAR DISEASES; SKELETAL MUSCLE;

ACYL COENZYME A; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CYCLOPHOSPHAMIDE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOSITIS; RITUXIMAB; STEROIDS;

EID: 85013805518     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-014-1207-z     Document Type: Review

References (8)

1. Sordet C, Goetz J, Sibilia J (2006) Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint bone Spine 73:646–654
2. Kao A, Lacomis D, Lucas M, Fertig N, Oddis C (2004) Anti-signal recognition particle autoantibody in patients with and without idiopathic inflammatory myopathy. Arthritis Rheum 50:209–215
3. Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L (2010) Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care Res 62:1328–1334
4. Needham M, Fabian V, Knezevic W, Panegyres P, Zilko P, Mastaglia F (2007) Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord 17:194–200
5. Mammen A, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering K, Casciola-Rosen L (2011) Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 63:713–721
6. Mammen AL, Pak K, Williams E, Brisson D, Coresh J, Selvin E, Gaudet D (2012) Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care Res (Hoboken) 64:269–272
7. Morikawa S, Murakami T, Yamazaki H, Izumi A, Saito Y, Hamakubo T, Kodama T (2005) Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins. J Atheroscler Thromb 12:121–131
8. Lee P, Greenfield J, Campbell L (2009) Vitamin D insufficiency—a novel mechanism of statin-induced myalgia? Clin Endocrinol (Oxf.) 71:154–155